JAMA Clinical Reviews
JAMA Clinical Reviews
Acute Respiratory Distress Syndrome: 2023 Guidelines
Loading
/

Acute Respiratory Distress Syndrome: 2023 Guidelines

JAMA Associate Editor David L. Simel, MD, MHS, discusses the latest European Society of Intensive Care Medicine (ESICM) Guidelines on Acute Respiratory Distress Syndrome, which were released in June 2023, with Derek C. Angus, MD, MPH, University of Pittsburgh.

Related Content:

More From Current Show

Heart transplant for patients with advanced heart failure can lead to improved survival and quality of life. Author...
Listen Now
Narcolepsy is a chronic neurologic disorder that causes severe daytime sleepiness and impaired quality of life. Author Tom...
Listen Now
Respiratory virus vaccine effectiveness and safety for influenza, RSV, and COVID-19 are reviewed, including new evidence, risks, and...
Listen Now
Cancer vaccines stimulate immune cells to recognize proteins or mutations found on or within cancer cells, facilitating destruction...
Listen Now
Idiopathic normal pressure hydrocephalus (iNPH) affects approximately 1% to 4% of adults aged 65 years and older and...
Listen Now
Rheumatoid arthritis can affect any synovial joint and cause irreversible damage, but early diagnosis and treatment with DMARDs...
Listen Now
POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem symptoms that affects an estimated...
Listen Now
Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment of alcohol use disorder. Author Stephen...
Listen Now

Related Episodes

No related episodes found.